Entecavir 31722-0834
Product NDC
31722-0834- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 21, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA205740
Need to source Entecavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Entecavir Anhydrous | 1 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Analog [EXT]
Packaging Options(4)
30 TABLET in 1 BOTTLE (31722-834-30)
10 TABLET in 1 BLISTER PACK (31722-834-31)
100 TABLET in 1 CARTON (31722-834-32)
90 TABLET in 1 BOTTLE (31722-834-90)